Yahoo Finance

MHRA approves AstraZeneca’s Trixeo Aerosphere inhaler for COPD

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has approved AstraZeneca's Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate or BGF ...
The Financial

AstraZeneca’s Trixeo Aerosphere recommended for approval in the EU

The FINANCIAL — AstraZeneca’s Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) has been recommended for marketing authorisation in the European Union (EU) for maintenance ...
Pharmabiz

AstraZeneca’s Trixeo Aerosphere approved in UK as first inhaled respiratory medicine using next-generation propellant with near-zero GWP

AstraZeneca’s Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate or BGF), already licensed for the treatment of chronic obstructive pulmonary disease ...
Pharmabiz

EU approves AstraZeneca’s Trixeo Aerosphere to treat moderate to severe COPD

AstraZeneca’s Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) has been approved in the European Union (EU) for maintenance treatment in adult patients with moderate to severe ...
Nasdaq

AstraZeneca's Trixeo Aerosphere Gets Positive CHMP Opinion For COPD Treatment

(RTTNews) - AstraZeneca Plc. (AZN.L, AZN) said Monday that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency has recommended Trixeo Aerosphere for marketing ...
PharmiWeb

Trixeo Aerosphere recommended for approval in the EU by CHMP for the maintenance treatment of COPD

AstraZeneca’s Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) has been recommended for marketing authorisation in the European Union (EU) for maintenance treatment in adult ...
PharmiWeb

Trixeo Aerosphere approved in the EU for maintenance treatment of COPD

AstraZeneca’s Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) has been approved in the European Union (EU) for maintenance treatment in adult patients with moderate to severe ...
London South East

Trixeo Aerosphere receives positive CHMP opinion

AstraZeneca's Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) has been recommended for marketing authorisation in the European Union (EU) for maintenance treatment in adult ...
Nasdaq

AstraZeneca Announces Approval Of Trixeo Aerosphere In EU - Quick Facts

(RTTNews) - AstraZeneca Plc (AZN.L, AZN) said Trixeo Aerosphere has been approved in the European Union for maintenance treatment in adult patients with moderate to severe chronic obstructive ...
London South East

Trixeo Aerosphere approved in the EU for COPD

Fourth major approval for AstraZenecaÕs triple-combination therapywhich is marketed as Breztri Aerosphere in the US, China and Japan AstraZenecaÕs Trixeo Aerosphere (formoterol fumarate/glycopyrronium ...